ABEO – Abeona Therapeutics Inc
Abeona Therapeutics Inc.ABEO
$5.78Name : Abeona Therapeutics Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $251,970,432.00
EPSttm : -2.05
Abeona Therapeutics Inc.
$5.78
0.69%$0.04Float Short %
6.46
Margin Of Safety %
Put/Call OI Ratio
0.24
EPS Next Q Diff
0.25
EPS Last/This Y
EPS This/Next Y
0.43
Price
5.78
Target Price
15.9
Analyst Recom
1
Performance Q
-1.28
Relative Volume
0.66
Beta
1.78
Ticker: ABEO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | ABEO | 5.23 | 0.22 | 0.00 | 2021 |
| 2025-01-24 | ABEO | 5.26 | 0.21 | 0.00 | 2035 |
| 2025-01-27 | ABEO | 5.3 | 0.21 | 0.35 | 2064 |
| 2025-01-28 | ABEO | 5.4 | 0.22 | 1.25 | 2156 |
| 2025-01-29 | ABEO | 5.46 | 0.27 | 0.00 | 2336 |
| 2025-01-30 | ABEO | 5.46 | 0.27 | 0.00 | 2336 |
| 2025-01-31 | ABEO | 5.53 | 0.26 | 0.00 | 2396 |
| 2025-02-03 | ABEO | 5.51 | 0.26 | 0.00 | 2408 |
| 2025-02-04 | ABEO | 5.86 | 0.25 | 0.02 | 2412 |
| 2025-02-05 | ABEO | 5.88 | 0.25 | 0.00 | 2450 |
| 2025-02-06 | ABEO | 5.88 | 0.25 | 0.50 | 2462 |
| 2025-02-07 | ABEO | 5.7 | 0.25 | 0.13 | 2472 |
| 2025-02-10 | ABEO | 5.83 | 0.26 | 0.00 | 2487 |
| 2025-02-11 | ABEO | 5.65 | 0.26 | 2.00 | 2507 |
| 2025-02-12 | ABEO | 5.98 | 0.27 | 0.00 | 2531 |
| 2025-02-13 | ABEO | 5.93 | 0.27 | 0.00 | 2531 |
| 2025-02-14 | ABEO | 6.03 | 0.27 | 0.00 | 2534 |
| 2025-02-18 | ABEO | 5.85 | 0.26 | 0.00 | 2559 |
| 2025-02-19 | ABEO | 5.85 | 0.25 | 0.56 | 2717 |
| 2025-02-20 | ABEO | 5.82 | 0.25 | 0.00 | 2733 |
| 2025-02-21 | ABEO | 5.78 | 0.24 | 1.25 | 2788 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | ABEO | 5.25 | 29.2 | - | -1.56 |
| 2025-01-24 | ABEO | 5.28 | 29.2 | - | -1.56 |
| 2025-01-27 | ABEO | 5.30 | 29.2 | - | -1.56 |
| 2025-01-28 | ABEO | 5.41 | 29.2 | - | -1.56 |
| 2025-01-29 | ABEO | 5.46 | 29.2 | - | -1.56 |
| 2025-01-30 | ABEO | 5.47 | 29.2 | - | -1.56 |
| 2025-01-31 | ABEO | 5.54 | 29.2 | - | -1.56 |
| 2025-02-03 | ABEO | 5.50 | 29.2 | - | -1.56 |
| 2025-02-04 | ABEO | 5.86 | 29.2 | - | -1.56 |
| 2025-02-05 | ABEO | 5.89 | 29.2 | - | -1.56 |
| 2025-02-06 | ABEO | 5.87 | 29.2 | - | -1.56 |
| 2025-02-07 | ABEO | 5.71 | 29.2 | - | -1.56 |
| 2025-02-10 | ABEO | 5.82 | 29.2 | - | -1.56 |
| 2025-02-11 | ABEO | 5.65 | 29.2 | - | -1.56 |
| 2025-02-12 | ABEO | 5.99 | 29.2 | - | -1.56 |
| 2025-02-13 | ABEO | 5.93 | 29.2 | - | -1.56 |
| 2025-02-14 | ABEO | 6.02 | 29.2 | - | -1.56 |
| 2025-02-18 | ABEO | 5.86 | 29.2 | - | -1.56 |
| 2025-02-19 | ABEO | 5.86 | 29.2 | - | -1.56 |
| 2025-02-20 | ABEO | 5.81 | 29.2 | - | -1.56 |
| 2025-02-21 | ABEO | 5.78 | 29.2 | - | -1.56 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | ABEO | -0.10 | -12.95 | 6.47 |
| 2025-01-24 | ABEO | -0.10 | -12.95 | 6.47 |
| 2025-01-27 | ABEO | -0.10 | -12.97 | 6.47 |
| 2025-01-28 | ABEO | -0.08 | -12.97 | 6.89 |
| 2025-01-29 | ABEO | -0.08 | -12.97 | 6.89 |
| 2025-01-30 | ABEO | -0.08 | -12.97 | 6.89 |
| 2025-01-31 | ABEO | -0.17 | -12.97 | 6.89 |
| 2025-02-03 | ABEO | -0.17 | -14.23 | 6.89 |
| 2025-02-04 | ABEO | -0.17 | -14.23 | 6.89 |
| 2025-02-05 | ABEO | -0.17 | -14.23 | 6.89 |
| 2025-02-06 | ABEO | -0.17 | -14.23 | 6.89 |
| 2025-02-07 | ABEO | -0.16 | -14.23 | 6.94 |
| 2025-02-10 | ABEO | -0.16 | -14.25 | 6.94 |
| 2025-02-11 | ABEO | -0.16 | -14.25 | 6.94 |
| 2025-02-12 | ABEO | -0.16 | -14.25 | 6.46 |
| 2025-02-13 | ABEO | -0.16 | -14.25 | 6.46 |
| 2025-02-14 | ABEO | -0.16 | -14.25 | 6.46 |
| 2025-02-18 | ABEO | -0.16 | -14.30 | 6.46 |
| 2025-02-19 | ABEO | -0.16 | -14.30 | 6.46 |
| 2025-02-20 | ABEO | -0.16 | -14.30 | 6.46 |
| 2025-02-21 | ABEO | -0.16 | -14.30 | 6.46 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.63
Avg. EPS Est. Current Quarter
-0.34
Avg. EPS Est. Next Quarter
-0.39
Insider Transactions
-0.16
Institutional Transactions
-14.3
Beta
1.78
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
7
Growth Score
25
Sentiment Score
46
Actual DrawDown %
94.7
Max Drawdown 5-Year %
-97.8
Target Price
15.9
P/E
Forward P/E
PEG
P/S
P/B
5.48
P/Free Cash Flow
EPS
-2.7
Average EPS Est. Cur. Y
-1.56
EPS Next Y. (Est.)
-1.12
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.66
Return on Equity vs Sector %
-174.4
Return on Equity vs Industry %
-158.8
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.1
EBIT Estimation
Abeona Therapeutics Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 84
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio.
stock quote shares ABEO – Abeona Therapeutics Inc Stock Price stock today
news today ABEO – Abeona Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ABEO – Abeona Therapeutics Inc yahoo finance google finance
stock history ABEO – Abeona Therapeutics Inc invest stock market
stock prices ABEO premarket after hours
ticker ABEO fair value insiders trading